FDA Approves Prolia, New Treatment for Osteopososis

FDA OKs Prolia for High-Risk Osteoporosis Twice-Yearly Injection Is First 'Biologic' Bone-Loss Treatment WebMD Health News By Daniel J. DeNoon Reviewed by Laura J. Martin, MD More from WebMD FDA...

Click here to read the full story.

Post a Comment

No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.